aluates Reports

$ 0.0

Automative

Subcutaneous Immunoglobulins - Global Market Insights and Sales Trends 2024

Published Date: November 2023

Report Code: QYRE-Auto-38X9072

Global Subcutaneous Immunoglobulins Market Insights and Forecast to 2028

BUY CHAPTERS

Subcutaneous Immunoglobulins - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-38X9072

Report

November 2023

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Shire (Baxalta)

Grifols S A

CSL Limited

Subcutaneous Immunoglobulins - Market Size

The global Subcutaneous Immunoglobulins market size is expected to reach US$ 9807.2 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029.

Subcutaneous Immunoglobulins - Market

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

The market is mainly driven by the significant applications of Subcutaneous Immunoglobulins in various end use industries. The expanding demands from the Primary Immunodeficiency, Secondary Immunodeficiency and Others,, are propelling Subcutaneous Immunoglobulins market. 0.1, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.2 segment is estimated at % CAGR for the next seven-year period.

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Purity, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Subcutaneous Immunoglobulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Subcutaneous Immunoglobulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Subcutaneous Immunoglobulins sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Subcutaneous Immunoglobulins covered in this report include Shire (Baxalta), Grifols and CSL, etc.

The global Subcutaneous Immunoglobulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Shire (Baxalta)

Grifols

CSL

Scope of Subcutaneous Immunoglobulins - Market Report

Report Metric	Details
Report Name	Subcutaneous Immunoglobulins - Market
Forecasted market size in 2029	US$ 9807.2 million
CAGR	12.1%
Forecasted years	2023 - 2029
Global Subcutaneous Immunoglobulins market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Immunoglobulins market, Segment by Purity:	0.1 0.2
Global Subcutaneous Immunoglobulins market, by Application	Primary Immunodeficiency Secondary Immunodeficiency Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Purity, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Subcutaneous Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Subcutaneous Immunoglobulins - Market size in 2029?

Ans: The Subcutaneous Immunoglobulins - Market size in 2029 will be US$ 9807.2 million.

What is the market share of major companies in Subcutaneous Immunoglobulins - Market?

Ans: Global top two manufacturers hold a share over 90%.

What are the Application segmentation covered in the Subcutaneous Immunoglobulins - Market report?

Ans: The Applications covered in the Subcutaneous Immunoglobulins - Market report are Primary Immunodeficiency, Secondary Immunodeficiency, Others

1 Subcutaneous Immunoglobulins Market Overview

1.1 Subcutaneous Immunoglobulins Product Overview

1.2 Subcutaneous Immunoglobulins Market Segment by Purity

1.2.1 0.1

1.2.2 0.2

1.3 Global Subcutaneous Immunoglobulins Market Size by Purity

1.3.1 Global Subcutaneous Immunoglobulins Market Size Overview by Purity (2018-2029)

1.3.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Purity (2018-2023)

1.3.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Purity (2024-2029)

1.4 Key Regions Market Size Segment by Purity

1.4.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)

1.4.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)

1.4.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)

1.4.4 Latin America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)

1.4.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)

2 Global Subcutaneous Immunoglobulins Market Competition by Company

2.1 Global Top Players by Subcutaneous Immunoglobulins Sales (2018-2023)

2.2 Global Top Players by Subcutaneous Immunoglobulins Revenue (2018-2023)

2.3 Global Top Players by Subcutaneous Immunoglobulins Price (2018-2023)

2.4 Global Top Manufacturers Subcutaneous Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Type

2.5 Subcutaneous Immunoglobulins Market Competitive Situation and Trends

2.5.1 Subcutaneous Immunoglobulins Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Subcutaneous Immunoglobulins Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2022)

2.7 Date of Key Manufacturers Enter into Subcutaneous Immunoglobulins Market

2.8 Key Manufacturers Subcutaneous Immunoglobulins Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Subcutaneous Immunoglobulins Status and Outlook by Region

3.1 Global Subcutaneous Immunoglobulins Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Subcutaneous Immunoglobulins Historic Market Size by Region

3.2.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2018-2023)

3.2.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2018-2023)

3.2.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Region

3.3.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2024-2029)

3.3.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2024-2029)

3.3.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Subcutaneous Immunoglobulins by Application

4.1 Subcutaneous Immunoglobulins Market Segment by Application

4.1.1 Primary Immunodeficiency

4.1.2 Secondary Immunodeficiency

4.1.3 Others

4.2 Global Subcutaneous Immunoglobulins Market Size by Application

4.2.1 Global Subcutaneous Immunoglobulins Market Size Overview by Application (2018-2029)

4.2.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Application (2018-2023)

4.2.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)

4.3.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)

5 North America Subcutaneous Immunoglobulins by Country

5.1 North America Subcutaneous Immunoglobulins Historic Market Size by Country

5.1.1 North America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)

5.1.3 North America Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)

5.2 North America Subcutaneous Immunoglobulins Forecasted Market Size by Country

5.2.1 North America Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)

5.2.2 North America Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)

6 Europe Subcutaneous Immunoglobulins by Country

6.1 Europe Subcutaneous Immunoglobulins Historic Market Size by Country

6.1.1 Europe Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)

6.1.3 Europe Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)

6.2 Europe Subcutaneous Immunoglobulins Forecasted Market Size by Country

6.2.1 Europe Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)

6.2.2 Europe Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)

7 Asia-Pacific Subcutaneous Immunoglobulins by Region

7.1 Asia-Pacific Subcutaneous Immunoglobulins Historic Market Size by Region

7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Subcutaneous Immunoglobulins Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Subcutaneous Immunoglobulins Forecasted Market Size by Region

7.2.1 Asia-Pacific Subcutaneous Immunoglobulins Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Subcutaneous Immunoglobulins Sales in Value by Region (2024-2029)

8 Latin America Subcutaneous Immunoglobulins by Country

8.1 Latin America Subcutaneous Immunoglobulins Historic Market Size by Country

8.1.1 Latin America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)

8.1.3 Latin America Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)

8.2 Latin America Subcutaneous Immunoglobulins Forecasted Market Size by Country

8.2.1 Latin America Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)

8.2.2 Latin America Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)

9 Middle East and Africa Subcutaneous Immunoglobulins by Country

9.1 Middle East and Africa Subcutaneous Immunoglobulins Historic Market Size by Country

9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Subcutaneous Immunoglobulins Forecasted Market Size by Country

9.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Shire (Baxalta)

10.1.1 Shire (Baxalta) Company Information

10.1.2 Shire (Baxalta) Introduction and Business Overview

10.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered

10.1.5 Shire (Baxalta) Recent Development

10.2 Grifols

10.2.1 Grifols Company Information

10.2.2 Grifols Introduction and Business Overview

10.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Grifols Subcutaneous Immunoglobulins Products Offered

10.2.5 Grifols Recent Development

10.3 CSL

10.3.1 CSL Company Information

10.3.2 CSL Introduction and Business Overview

10.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)

10.3.4 CSL Subcutaneous Immunoglobulins Products Offered

10.3.5 CSL Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Subcutaneous Immunoglobulins Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Subcutaneous Immunoglobulins Industrial Chain Analysis

11.4 Subcutaneous Immunoglobulins Market Dynamics

11.4.1 Subcutaneous Immunoglobulins Industry Trends

11.4.2 Subcutaneous Immunoglobulins Market Drivers

11.4.3 Subcutaneous Immunoglobulins Market Challenges

11.4.4 Subcutaneous Immunoglobulins Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Subcutaneous Immunoglobulins Distributors

12.3 Subcutaneous Immunoglobulins Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Shire (Baxalta)

Grifols S A

CSL Limited

List of Tables

Table 1. Major Company of 0.1

Table 2. Major Company of 0.2

Table 3. Global Subcutaneous Immunoglobulins Sales by Purity 2018 VS 2022 VS 2029 (US$ Million)

Table 4. Global Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (K Bottle)

Table 5. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2018-2023)

Table 6. Global Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US& Million)

Table 7. Global Subcutaneous Immunoglobulins Market Share in Value by Purity (2018-2023)

Table 8. Global Subcutaneous Immunoglobulins Price by Purity (2018-2023) & (USD/Bottle)

Table 9. Global Subcutaneous Immunoglobulins Sales by Purity (2024-2029) & (K Bottle)

Table 10. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2024-2029)

Table 11. Global Subcutaneous Immunoglobulins Sales by Purity (2024-2029) & (US$ Million)

Table 12. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Purity (2024-2029)

Table 13. Global Subcutaneous Immunoglobulins Price by Purity (2024-2029) & (USD/Bottle)

Table 14. North America Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (K Bottle)

Table 15. North America Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US$ Million)

Table 16. Europe Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2018-2023)

Table 17. Europe Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US$ Million)

Table 18. Asia-Pacific Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2018-2023)

Table 19. Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US$ Million)

Table 20. Latin America Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2018-2023)

Table 21. Latin America Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US$ Million)

Table 22. Middle East and Africa Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2018-2023)

Table 23. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2018-2023) & (US$ Million)

Table 24. Global Subcutaneous Immunoglobulins Sales by Company (2018-2023) & (K Bottle)

Table 25. Global Subcutaneous Immunoglobulins Sales Share by Company (2018-2023)

Table 26. Global Subcutaneous Immunoglobulins Revenue by Company (2018-2023) & (US$ Million)

Table 27. Global Subcutaneous Immunoglobulins Revenue Share by Company (2018-2023)

Table 28. Global Market Subcutaneous Immunoglobulins Price by Company (2018-2023) & (USD/Bottle)

Table 29. Global Subcutaneous Immunoglobulins Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 30. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2022)

Table 32. Date of Key Manufacturers Enter into Subcutaneous Immunoglobulins Market

Table 33. Key Manufacturers Subcutaneous Immunoglobulins Product Type

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Subcutaneous Immunoglobulins Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 36. Global Subcutaneous Immunoglobulins Sales by Region (2018-2023) & (K Bottle)

Table 37. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2018-2023)

Table 38. Global Subcutaneous Immunoglobulins Sales by Region (2018-2023) & (US$ Million)

Table 39. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2018-2023)

Table 40. Global Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)

Table 41. Global Subcutaneous Immunoglobulins Sales by Region (2024-2029) & (K Bottle)

Table 42. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2024-2029)

Table 43. Global Subcutaneous Immunoglobulins Sales by Region (2024-2029) & (US$ Million)

Table 44. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2024-2029)

Table 45. Global Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2024-2029)

Table 46. Global Subcutaneous Immunoglobulins Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 47. Global Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (K Bottle)

Table 48. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2018-2023)

Table 49. Global Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 50. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2018-2023)

Table 51. Global Subcutaneous Immunoglobulins Price by Application (2018-2023) & (USD/Bottle)

Table 52. Global Subcutaneous Immunoglobulins Sales by Application (2024-2029) & (K Bottle)

Table 53. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2024-2029)

Table 54. Global Subcutaneous Immunoglobulins Sales by Application (2024-2029) & (US$ Million)

Table 55. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2024-2029)

Table 56. Global Subcutaneous Immunoglobulins Price by Application (2024-2029) & (USD/Bottle)

Table 57. North America Subcutaneous Immunoglobulins Sales by Application (2018-2023) (K Bottle)

Table 58. North America Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 59. Europe Subcutaneous Immunoglobulins Sales by Application (2018-2023) (K Bottle)

Table 60. Europe Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 61. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2018-2023) (K Bottle)

Table 62. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 63. Latin America Subcutaneous Immunoglobulins Sales by Application (2018-2023) (K Bottle)

Table 64. Latin America Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 65. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2018-2023) (K Bottle)

Table 66. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2018-2023) & (US$ Million)

Table 67. North America Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (K Bottle)

Table 68. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2018-2023)

Table 69. North America Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (US$ Million)

Table 70. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2018-2023)

Table 71. North America Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (K Bottle)

Table 72. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2024-2029)

Table 73. North America Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (US$ Million)

Table 74. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2024-2029)

Table 75. Europe Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (K Bottle)

Table 76. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2018-2023)

Table 77. Europe Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (US$ Million)

Table 78. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2018-2023)

Table 79. Europe Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (K Bottle)

Table 80. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2024-2029)

Table 81. Europe Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (US$ Million)

Table 82. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2024-2029)

Table 83. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2018-2023) & (K Bottle)

Table 84. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2018-2023)

Table 85. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2018-2023) & (US$ Million)

Table 86. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2018-2023)

Table 87. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2024-2029) & (K Bottle)

Table 88. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2024-2029)

Table 89. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2024-2029) & (US$ Million)

Table 90. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2024-2029)

Table 91. Latin America Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (K Bottle)

Table 92. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2018-2023)

Table 93. Latin America Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (US$ Million)

Table 94. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2018-2023)

Table 95. Latin America Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (K Bottle)

Table 96. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2024-2029)

Table 97. Latin America Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (US$ Million)

Table 98. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2024-2029)

Table 99. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (K Bottle)

Table 100. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2018-2023)

Table 101. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2018-2023) & (US$ Million)

Table 102. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2018-2023)

Table 103. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (K Bottle)

Table 104. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Volume by Country (2024-2029)

Table 105. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2024-2029) & (US$ Million)

Table 106. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Country (2024-2029)

Table 107. Shire (Baxalta) Company Information

Table 108. Shire (Baxalta) Introduction and Business Overview

Table 109. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2023)

Table 110. Shire (Baxalta) Subcutaneous Immunoglobulins Product

Table 111. Shire (Baxalta) Recent Development

Table 112. Grifols Company Information

Table 113. Grifols Introduction and Business Overview

Table 114. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2023)

Table 115. Grifols Subcutaneous Immunoglobulins Product

Table 116. Grifols Recent Development

Table 117. CSL Company Information

Table 118. CSL Introduction and Business Overview

Table 119. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2018-2023)

Table 120. CSL Subcutaneous Immunoglobulins Product

Table 121. CSL Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Subcutaneous Immunoglobulins Market Trends

Table 125. Subcutaneous Immunoglobulins Market Drivers

Table 126. Subcutaneous Immunoglobulins Market Challenges

Table 127. Subcutaneous Immunoglobulins Market Restraints

Table 128. Subcutaneous Immunoglobulins Distributors List

Table 129. Subcutaneous Immunoglobulins Downstream Customers

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Subcutaneous Immunoglobulins Product Picture

Figure 2. Global Subcutaneous Immunoglobulins Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Subcutaneous Immunoglobulins Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Subcutaneous Immunoglobulins Sales Status and Outlook (2018-2029) & (K Bottle)

Figure 5. Product Picture of 0.1

Figure 6. Global 0.1 Sales YoY Growth (2018-2029) & (K Bottle)

Figure 7. Product Picture of 0.2

Figure 8. Global 0.2 Sales YoY Growth (2018-2029) & (K Bottle)

Figure 9. Global Subcutaneous Immunoglobulins Sales by Purity (2018-2029) & (US$ Million)

Figure 10. Global Subcutaneous Immunoglobulins Sales Market Share by Purity in 2022 & 2029

Figure 11. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity in 2022

Figure 12. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Purity in 2022

Figure 13. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity in 2022

Figure 14. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Purity in 2022

Figure 15. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity in 2022

Figure 16. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Purity in 2022

Figure 17. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity in 2022

Figure 18. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Purity in 2022

Figure 19. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity in 2022

Figure 20. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Purity in 2022

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Subcutaneous Immunoglobulins Sales in 2022

Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Subcutaneous Immunoglobulins Revenue in 2022

Figure 23. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 24. Product Picture of Primary Immunodeficiency

Figure 25. Global Primary Immunodeficiency Sales YoY Growth (2018-2029) & (K Bottle)

Figure 26. Product Picture of Secondary Immunodeficiency

Figure 27. Global Secondary Immunodeficiency Sales YoY Growth (2018-2029) & (K Bottle)

Figure 28. Product Picture of Others

Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Bottle)

Figure 30. Global Subcutaneous Immunoglobulins Sales by Application (2018-2029) & (US$ Million)

Figure 31. Global Subcutaneous Immunoglobulins Sales Market Share by Application in 2022 & 2029

Figure 32. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2022

Figure 33. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2022

Figure 34. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2022

Figure 35. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2022

Figure 36. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2022

Figure 37. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2022

Figure 38. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2022

Figure 39. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2022

Figure 40. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2022

Figure 41. Key Raw Materials Price

Figure 42. Subcutaneous Immunoglobulins Manufacturing Cost Structure

Figure 43. Subcutaneous Immunoglobulins Industrial Chain Analysis

Figure 44. Channels of Distribution

Figure 45. Distributors Profiles

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions